mRNA vaccine tackles deadly brain cancer in human trial [Video]

Glioblastoma is one of the most deadly cancers, with few treatment options available. Now, a small human clinical trial has demonstrated an mRNA vaccine that quickly rallies the immune system to fight off the tumors, with promising results.

Glioblastoma is the most common form of brain cancer, and unfortunately it’s also the most aggressive. Treatment involves a combination of surgical removal, radiation and chemotherapy, however the disease almost always comes back. Patients usually live about a year after diagnosis, with only about 5% of patients surviving longer than five years.

A new study from the University of Florida could soon add a better option for patients – an mRNA cancer vaccine. This technology, best known for COVID-19 vaccines, has been shown to quickly alert the immune system to attack glioblastoma more effectively, in mice, dogs and now humans.

As you might remember from the heady days of 2020 and 2021, mRNA moleculesare essentially natural blueprints that …